134 related articles for article (PubMed ID: 2062767)
1. Treatment of enteric hyperoxaluria.
Harper J; Mansell MA
Postgrad Med J; 1991 Mar; 67(785):219-22. PubMed ID: 2062767
[No Abstract] [Full Text] [Related]
2. Future treatments for hyperoxaluria.
Burns Z; Knight J; Fargue S; Holmes R; Assimos D; Wood K
Curr Opin Urol; 2020 Mar; 30(2):171-176. PubMed ID: 31895888
[TBL] [Abstract][Full Text] [Related]
3. [Oxalates and the digestive tract].
Gendre JP
Ann Gastroenterol Hepatol (Paris); 1990; 26(2):81-4. PubMed ID: 2189358
[No Abstract] [Full Text] [Related]
4. [Hyperoxaluria and renal calculi].
Buño Soto A; Torres Jiménez R; García Puig J; Mateos Antón F
Arch Esp Urol; 1996 Sep; 49(7):707-26. PubMed ID: 9020008
[TBL] [Abstract][Full Text] [Related]
5. The management of patients with enteric hyperoxaluria.
Asplin JR
Urolithiasis; 2016 Feb; 44(1):33-43. PubMed ID: 26645872
[TBL] [Abstract][Full Text] [Related]
6. Enteric and mild hyperoxaluria.
Sutton RA; Walker VR
Miner Electrolyte Metab; 1994; 20(6):352-60. PubMed ID: 7783697
[TBL] [Abstract][Full Text] [Related]
7. Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy.
Sidhu H; Schmidt ME; Cornelius JG; Thamilselvan S; Khan SR; Hesse A; Peck AB
J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S334-40. PubMed ID: 10541258
[TBL] [Abstract][Full Text] [Related]
8. Reduced active transcellular intestinal oxalate secretion contributes to the pathogenesis of obesity-associated hyperoxaluria.
Amin R; Asplin J; Jung D; Bashir M; Alshaikh A; Ratakonda S; Sharma S; Jeon S; Granja I; Matern D; Hassan H
Kidney Int; 2018 May; 93(5):1098-1107. PubMed ID: 29395336
[TBL] [Abstract][Full Text] [Related]
9. [Pancreatico-biliary secretion in enteral hyperoxaluria].
Möller T; Appelt G; Müller G; Rogos R; Schütte W; Wegner D
Dtsch Z Verdau Stoffwechselkr; 1988; 48(6):315-20. PubMed ID: 3254836
[TBL] [Abstract][Full Text] [Related]
10. What is new in primary hyperoxaluria?
Leumann E; Hoppe B
Nephrol Dial Transplant; 1999 Nov; 14(11):2556-8. PubMed ID: 10534483
[No Abstract] [Full Text] [Related]
11. The hyperoxaluric syndromes.
Wandzilak TR; Williams HE
Endocrinol Metab Clin North Am; 1990 Dec; 19(4):851-67. PubMed ID: 2081515
[TBL] [Abstract][Full Text] [Related]
12. [Metabolism and pathophysiology of oxalic acid].
Berg W
Z Urol Nephrol; 1990 Sep; 83(9):481-8. PubMed ID: 2267860
[TBL] [Abstract][Full Text] [Related]
13. Oxalate creatinine ratio in the peritoneal fluid of patients with primary hyperoxaluria.
Mattoo TK; Katawee Y
Nephron; 1992; 60(4):496-7. PubMed ID: 1584333
[No Abstract] [Full Text] [Related]
14. Hyperoxaluria and renal calculi.
Woolfson RG; Mansell MA
Postgrad Med J; 1994 Oct; 70(828):695-8. PubMed ID: 7831162
[No Abstract] [Full Text] [Related]
15. Anemia in patient with primary hyperoxaluria and bone marrow involvement by oxalate crystals.
Mykytiv V; Campoy Garcia F
Hematol Oncol Stem Cell Ther; 2018 Jun; 11(2):118-121. PubMed ID: 29066173
[TBL] [Abstract][Full Text] [Related]
16. Hyperoxaluria in idiopathic calcium oxalate nephrolithiasis.
Yendt ER
Md Med J; 1988 Nov; 37(11):857-60. PubMed ID: 3185157
[No Abstract] [Full Text] [Related]
17. Oxalate dynamics in chronic renal failure. Comparison with normal subjects and patients with primary hyperoxaluria.
Morgan SH; Purkiss P; Watts RW; Mansell MA
Nephron; 1987; 46(3):253-7. PubMed ID: 3306417
[TBL] [Abstract][Full Text] [Related]
18. Oxalate degrading bacteria: new treatment option for patients with primary and secondary hyperoxaluria?
Hoppe B; von Unruh G; Laube N; Hesse A; Sidhu H
Urol Res; 2005 Nov; 33(5):372-5. PubMed ID: 16284877
[TBL] [Abstract][Full Text] [Related]
19. Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass.
Nelson WK; Houghton SG; Milliner DS; Lieske JC; Sarr MG
Surg Obes Relat Dis; 2005; 1(5):481-5. PubMed ID: 16925274
[TBL] [Abstract][Full Text] [Related]
20. Re: dietary hyperoxaluria is not reduced by treatment with lactic acid bacteria.
Assimos DG
J Urol; 2014 Jun; 191(6):1810. PubMed ID: 25280289
[No Abstract] [Full Text] [Related]
[Next] [New Search]
